Metastatic Prostate Cancer

This week’s episode will be focusing on one of the GI plenary session abstracts presented at the ASCO Annual Meeting 2025, the MATTERHORN trial: phase 3 durvalumab + FLOT which is 5FU leucovorin, oxaliplatin and docetaxel in resectable gastric or GE junction CA. 

This week’s episode will be focusing on how to prepare for the start of heme/onc fellowship! We will go over some general advice on how to succeed, study tips and resources we used throughout fellowship as well as some tips on how to stay academically productive during training i ... Show More

This week’s episode will be focusing on one of the 2025 plenary sessions: SERENA-6, Camizestrant, a novel selective estrogen receptor degrader (SERD) + CDK 4/6i for tx of emergent ESR1 during 1L endocrine-based therapy + ahead of progression in stage 4 HR+/Her-2 negative breast c ... Show More

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ... Show More

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Ted Schaeffer is an internationally recognized urologist specializing in prostate cancer and a returning guest on The Drive. In this episode, Ted pr ... Show More

What to look out for in bladder, prostate and renal cancer at this year's meeting. 

Olympic cyclist Sir Chris Hoy is calling for more prostate cancer testing after he was diagnosed with terminal cancer. Prostate cancer can often present without symptoms, and for people like Sir Chris, this can mean it isn't diagnosed until it has spread and become incurable. Unl ... Show More

Thomas Zilli discusses controversies around radiotherapy in prostate cancer. 

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Join Lauren Bright Pacheco at the 2024 ASCO Annual Meeting in Chicago, as she investigates the advancements in prostate cancer care.  Dr. Mohammad Atiq shares ways innovative treatments are paving the ... Show More

One in eight men will be diagnosed with prostate cancer, and President Biden’s recent diagnosis has many people asking: Am I at risk? Should I get screened? Dr. Sanjay Gupta breaks down what to know about PSA tests, family history, screening age, and how your diet might factor in ... Show More

March is colon cancer awareness month so in today's episode, I discuss oncologic treatment options for colorectal cancer with Dr. Hardeep Phull. Dr. Phull is Medical Director of Oncology at Palomar Health and Clinical Instructor at the University of California San Diego. He ... Show More

La prostate est une glande située sous la vessie chez l’homme et qui participe à la production du liquide séminal. Hypertrophie bénigne, prostatite, cancer…Plusieurs maladies peuvent la toucher, en lien avec le vieillissement. Comment le temps et l'âge agissent-ils sur la santé d ... Show More

Among men aged 15 to 44 years, testicular tumours are the most common cancer diagnosed. And testicular cancer can cause considerable morbidity and mortality. So it is important that we get the diagnosis and management of this condition right. To find out more about this problem a ... Show More